News Focus
News Focus
Post# of 257691
Next 10
Followers 843
Posts 123055
Boards Moderated 9
Alias Born 09/05/2002

Re: Biowatch post# 208593

Tuesday, 01/31/2017 12:51:24 PM

Tuesday, January 31, 2017 12:51:24 PM

Post# of 257691
It's curious that no FDA approval to date of an FoB under the 351(k) pathway has been an oncology drug. (I'm not counting Neupogen/Neulasta as oncology drugs because they don't treat cancer.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today